GlassScriptPhysician profile
Kirk G Bowden
NPI 1255592994
$51,058.99
in general payments reported to CMS, 2019-2025
64 companies · $1,868 in 2025
The $1,868 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,915 · 2020: $14K · 2021: $3,287 · 2022: $7,394 · 2023: $6,111 · 2024: $8,094 · 2025: $1,868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Food and Beverage: $6,361 · Travel and Lodging: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Food and Beverage | $6,360.53 |
| Travel and Lodging | $2,211.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $13,647.62 | 2019-2020 | |
| Boston Scientific Corporation | $9,373.21 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $6,846.23 | 2019-2025 | Proclaim, Prodigy |
| Tersera Therapeutics LLC | $6,740.46 | 2019-2025 | Prialt |
| Medtronic, INC. | $5,602.00 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Ascenda |
| Spinal Simplicity, LLC | $1,622.58 | 2021-2024 | Ha Minuteman G3-R |
| Vertiflex, INC. | $1,306.64 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $562.65 | 2019-2025 | Relistor |
| Nevro Corp. | $519.98 | 2019-2023 | Senza |
| Saluda Medical Americas, INC. | $499.55 | 2023-2025 | Evoke, Evoke Scs |
| Collegium Pharmaceutical, INC. | $466.07 | 2019-2025 | Xtampza, Belbuca |
| Abbvie INC. | $335.10 | 2021-2025 | Ubrelvy, Botox |
| Nalu Medical, INC. | $305.74 | 2021-2024 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $270.54 | 2023-2025 | Prospera, Biotronik |
| Relievant Medsystems, INC. | $229.18 | 2019-2023 | Intracept |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Bowden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.